Genetic Variants Associated With Anxiety and Stress-Related Disorders
Authors: Sandra M. Meier, Kalevi Trontti, Kirstin L. Purves, Thomas Damm Als, Jakob Grove, Mikaela Laine, Marianne Giørtz Pedersen, Jonas Bybjerg-Grauholm, Marie Bækved-Hansen, Ewa Sokolowska, Preben B. Mortensen, David M. Hougaard, Thomas Werge, Merete Nordentoft, Gerome Breen, Anders D. Børglum, Thalia C. Eley, Iiris Hovatta, Manuel Mattheisen, Ole Mors
Journal: JAMA Psychiatry (2019)

<h3>Importance</h3> Anxiety and stress-related disorders are among the most common mental disorders. Although family and twin studies indicate that both genetic and environmental factors play an important role underlying their etiology, the genetic underpinnings of anxiety and stress-related disorders are poorly understood. <h3>Objectives</h3> To estimate the single-nucleotide polymorphism–based heritability of anxiety and stress-related disorders; to identify novel genetic risk variants, genes, or biological pathways; to test for pleiotropic associations with other psychiatric traits; and to evaluate the association of psychiatric comorbidities with genetic findings. <h3>Design, Setting, Participants</h3> This genome-wide association study included individuals with various anxiety and stress-related diagnoses and controls derived from the population-based Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH) study. Lifetime diagnoses of anxiety and stress-related disorders were obtained through the national Danish registers. Genes of interest were further evaluated in mice exposed to chronic social defeat. The study was conducted between June 2016 and November 2018. <h3>Main Outcomes and Measures</h3> Diagnoses of a relatively broad diagnostic spectrum of anxiety and stress-related disorders. <h3>Results</h3> The study sample included 12 655 individuals with various anxiety and stress-related diagnoses and 19 225 controls. Overall, 17 740 study participants (55.6%) were women. A total of 7308 participants (22.9%) were born between 1981-1985, 8840 (27.7%) between 1986-1990, 8157 (25.6%) between 1991-1995, 5918 (18.6%) between 1996-2000, and 1657 (5.2%) between 2001-2005. Standard association analysis revealed variants in<i>PDE4B</i>to be associated with anxiety and stress-related disorder (rs7528604;<i>P</i> = 5.39 × 10<sup>−11</sup>; odds ratio = 0.89; 95% CI, 0.86-0.92). A framework of sensitivity analyses adjusting for mental comorbidity supported this result showing consistent association of<i>PDE4B</i>variants with anxiety and stress-related disorder across analytical scenarios. In mouse models, alterations in<i>Pde4b</i>expression were observed in those mice displaying anxiety-like behavior after exposure to chronic stress in the prefrontal cortex (<i>P</i> = .002;<i>t</i> = −3.33) and the hippocampus (<i>P</i> = .001;<i>t</i> = −3.72). We also found a single-nucleotide polymorphism heritability of 28% (standard error = 0.027) and that the genetic signature of anxiety and stress-related overlapped with psychiatric traits, educational outcomes, obesity-related phenotypes, smoking, and reproductive success. <h3>Conclusions and Relevance</h3> This study highlights anxiety and stress-related disorders as complex heritable phenotypes with intriguing genetic correlations not only with psychiatric traits, but also with educational outcomes and multiple obesity-related phenotypes. Furthermore, we highlight the candidate gene<i>PDE4B</i>as a robust risk locus pointing to the potential of<i>PDE4B</i>inhibitors in treatment of these disorders.